The most frequently seen primary oncogenic event in melanomas is the BRAF-activating mutation, which leads to permanent activation of the MAPK pathway and subsequently promotes uncontrolled cell proliferation, survival, and other oncogenic processes [6,7]. Here, BRAF is linked to melanoma.